Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Treatment in IntraCerebal Hemorrhage To Enhance Hematoma Resolution
NCT07458815Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Mar 2026
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in intracerebral hemorrhage (ICH) (2 arms), sponsored by The University of Hong Kong. Primary endpoints: Change in hematoma volume at 14 days and Incidence of hypercalcemia and vitamin D-related adverse events at 26 weeks. Started Mar 2026; status: recruiting.
02
Drugs
vitamin d
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07458815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07458815.